Financhill
Back

ImmunityBio Quote, Financials, Valuation and Earnings

ImmunityBio Price Quote

$7.76
-0.16 (-2.02%)
(Updated: May 9, 2024 at 9:50 AM ET)

ImmunityBio Key Stats

Buy
75
ImmunityBio (IBRX) is a Buy

Day range:
$7.68 - $8.14
52-week range:
$1.25 - $10.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6,474.07
P/B ratio:
0%

Volume:
5M
Avg. volume:
10.2M
1-year change:
23.56%
Market cap:
$5.3B
Revenue:
$622K
EPS:
$-1.16

How Much Does ImmunityBio Make?

Is ImmunityBio Growing As A Company?

  • What Is ImmunityBio's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.9%
  • What Is ImmunityBio's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ImmunityBio Stock Price Performance

  • Did ImmunityBio Stock Go Up Last Month?
    ImmunityBio share price went up by 28.36% last month
  • Did IBRX's Share Price Rise Over The Last Year?
    IBRX share price rose by 23.56% over the past 1 year

What Is ImmunityBio 52-Week High & Low?

  • What Is ImmunityBio’s 52-Week High Share Price?
    ImmunityBio has traded as high as $10.53 over the past 52 weeks
  • What Is ImmunityBio’s 52-Week Low Share Price?
    ImmunityBio has traded as low as $1.25 over the past 52 weeks

ImmunityBio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ImmunityBio?

  • How Much Debt Does ImmunityBio Have?
    Total long term debt quarterly is $681.5M
  • How Much Cash Does ImmunityBio Have?
    Cash and short term investments quarterly total is $266.5M
  • What Is ImmunityBio’s Book Value Per Share?
    Book value per share is -0.88

Is ImmunityBio Cash Flow Positive?

  • What Is IBRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$366.8M
  • What Is ImmunityBio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $558.3M
  • What Is ImmunityBio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$30.5M

ImmunityBio Return On Invested Capital

  • Is Management Doing A Good Job?
    IBRX return on invested capital is -327.37%
  • What Is ImmunityBio Return On Assets?
    ROA measures how assets are converting to revenues and is -150.79%
  • What Is IBRX Return On Equity?
    ROE is a measure of profitability and is 0%

ImmunityBio Earnings Date & Stock Price

  • What Is ImmunityBio's Stock Price Today?
    A single share of IBRX can be purchased today for 7.92
  • What Is ImmunityBio’s Stock Symbol?
    ImmunityBio trades on the nasdaq under the ticker symbol: IBRX
  • When Is ImmunityBio’s Next Earnings Date?
    The next quarterly earnings date for ImmunityBio is scheduled on May 10, 2024
  • When Is IBRX's next ex-dividend date?
    ImmunityBio's next ex-dividend date is May 9, 2024
  • How To Buy ImmunityBio Stock?
    You can buy ImmunityBio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

ImmunityBio Competitors

  • Who Are ImmunityBio's Competitors?
    Below is a list of companies who compete with ImmunityBio or are related in some way:
    • Abeona Therapeutics Inc (ABEO)
    • Chromocell Therapeutics Corp (CHRO)
    • iBio Inc (IBIO)
    • Lixte Biotechnology Holdings Inc (LIXT)
    • Vanda Pharmaceuticals Inc (VNDA)

ImmunityBio Dividend Yield

Data Unavailable

ImmunityBio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 90.41% 456%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 7.50
Downside from Last Price: -5.3%

Major Shareholders

  • How many IBRX shares are owned by institutional investors?
    98.5M IBRX shares are owned by institutional investors
  • How many IBRX shares are owned by insiders?
    4.3M IBRX shares are owned by insiders